Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapy

被引：17
|
作者：
Shi, Jing [1 ]
Li, Ming [1 ]
Yang, Rongzhi [1 ]
机构：
[1] Zhengzhou Univ, Dept Orthoped Surg, Luoyang Cent Hosp, Luoyang 471009, Peoples R China
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 09期
关键词：
adjuvant chemotherapy; adverse effects; immunotherapy; osteosarcoma; PD1; phenotype; poor response; prognostic factor; retrospective; TILs; SOUTHWEST-ONCOLOGY-GROUP; HIGH-GRADE OSTEOSARCOMA; METASTATIC MELANOMA; T-CELLS; NONMETASTATIC OSTEOSARCOMA; PROGNOSTIC-FACTORS; EWINGS-SARCOMA; OSTEO-SARCOMA; PHASE-II; CANCER;
D O I：
10.2217/imt-2020-0107
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To investigate the efficacy of adjuvant chemotherapy plus tumor-infiltrating lymphocytes (TILs) therapy in osteosarcoma patients with a poor response to neoadjuvant chemotherapy. Materials & methods: 40 patients received adjuvant chemotherapy (Group 1) and 40 patients received adjuvant chemotherapy plus TILs therapy (Group 2). Disease-free survival (DFS) and overall survival (OS) were analyzed by Kaplan-Meier analysis. Results: The median DFS (mDFS; 65.3 months) and median OS (mOS; 95.8 months) in Group 2 were significantly prolonged compared with those in Group 1 (55.5 months for mDFS and 80.4 months for mOS). Univariate and multivariate analyses indicated that a greater number of TILs transfused was an independent prognostic factor for both mDFS and mOS. Conclusion: Adjuvant chemotherapy plus TILs therapy may prolong survival of patients with a poor response to neoadjuvant chemotherapy.
引用
收藏
页码：641 / 652
页数：12
相关论文
共 50 条
  • [31] Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
    Hong, Jin
    Rui, Weiwei
    Fei, Xiaochun
    Chen, Xiaosong
    Shen, Kunwei
    [J]. CANCER MEDICINE, 2021, 10 (22): : 7921 - 7933
  • [32] Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
    Xiao-Long Qian
    Xiao-Qing Xia
    Ya-Qing Li
    Yu-Mian Jia
    Yuan-Yuan Sun
    Yuan-Ming Song
    Hui-Qin Xue
    Yan-Fei Hao
    Jin Wang
    Xiao-Zi Wang
    Chen-Ying Liu
    Xin-Min Zhang
    Li-Na Zhang
    Xiao-Jing Guo
    [J]. Scientific Reports, 13
  • [33] Predictive and prognostic value of tumor-infiltrating lymphocytes in breast cancer treated with neoadjuvant chemotherapy.
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Saito, Junichi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [34] Pathological response and tumor-infiltrating-lymphocytes post neoadjuvant chemotherapy.
    Roque, Katia Mercedes
    Nino, Marco Galvez
    Castaneda Altamirano, Carlos Arturo
    Garcia, Miluska Castillo
    Sanchez, Joselyn
    Bernabe, Luis A.
    Fuentes, Hugo Alejandro
    Sandival, Gustavo
    Cotrina, Jose M.
    Dunstan, Jorge Antonio
    Abugattas, Julio
    Mantilla, Raul
    De La Cruz, Miguel
    Gomez, Henry Leonidas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients
    Mezquita, L.
    Gataa, I.
    Rossoni, C.
    Auclin, E.
    Kossai, M.
    Aboubakar, F.
    Le Moulec, S.
    Masse, J.
    Masson, M.
    Radosevic-Robin, N.
    Rouanne, M.
    Bluthgen, M.
    Caramella, C.
    Hendriks, L.
    Gazzah, A.
    Planchard, D.
    Pignon, J.
    Besse, B.
    Adam, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S351 - S352
  • [36] Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
    Zhu, Jingjing
    De Tenbossche, CLine G. Powis
    Cane, Stefania
    Colau, Didier
    Van Baren, Nicolas
    Lurquin, Christophe
    Schmitt-Verhulst, Anne-Marie
    Liljestrom, Peter
    Uyttenhove, Catherine
    Van den Eynde, Benoit J.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [37] Postoperative　immunotherapy　for　patients　with　hepatocarcinoma　using　tumor-infiltrating　lymphocytes
    王一
    陈汉
    吴孟超
    宝建中
    丛文铭
    [J]. 中华医学杂志(英文版), 1997, (02) : 114 - 117
  • [38] Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
    Jingjing Zhu
    Céline G. Powis de Tenbossche
    Stefania Cané
    Didier Colau
    Nicolas van Baren
    Christophe Lurquin
    Anne-Marie Schmitt-Verhulst
    Peter Liljeström
    Catherine Uyttenhove
    Benoit J. Van den Eynde
    [J]. Nature Communications, 8
  • [39] A NEW APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF CANCER WITH TUMOR-INFILTRATING LYMPHOCYTES
    ROSENBERG, SA
    SPIESS, P
    LAFRENIERE, R
    [J]. SCIENCE, 1986, 233 (4770) : 1318 - 1321
  • [40] Postoperative　immunotherapy　for　patients　with　hepatocarcinoma　using　tumor-infiltrating　lymphocytes
    王一，陈汉，吴孟超，宝建中，丛文铭
    [J]. Chinese Medical Journal, 1997, (02)
12345